Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir QT Interval Study in Healthy Volunteers
NCT00312182Phase 4Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, single-blind trial of nelfinavir in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Pfizer. Primary endpoint: Fridericia-corrected QT interval at Day 4. Started Mar 2006; status: completed.
02
Drugs
nelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00312182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312182.